UBS Remains Sidelined on New Relic (NEWR) as Challenges Overshadow 2Q Upside
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
New Relic (NEWR) Tops Q2 EPS by 8c
November 7, 2016 4:21 PM ESTNew Relic (NYSE: NEWR) reported Q2 EPS of ($0.09), $0.08 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $63.4 million versus the consensus estimate of $61.93 million.
"New Relic is rapidly becoming the global enterprise standard for a new category of software we call Digital Intelligence. At the end of... More
Trading Radar for 11/7: MGM Resorts (MGM), LendingClub (LC), Dean Foods (DF), Ferrari (RACE), Sysco (SYY) Report
November 4, 2016 3:49 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.19
Altisource Residential (Nasdaq: RESI) - consensus loss $0.48
Amicus Therapeutics (Nasdaq: FOLD) - consensus loss $0.34
ArQule (Nasdaq: ARQL) - consensus loss $0.09
Aralez Pharma (Nasdaq: ARLZ) - consensus loss $0.37
Ardelyx (Nasdaq: ARDX) -... More
